Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...
Die LBBW hat im vergangenen Jahr zwar erneut mehr als eine Milliarde Euro verdient, im Vergleich zum Vorjahr schrumpfte das ...
Der ehemalige Co-Leiter des Prime-Brokerage-Geschäfts der Credit Suisse hat von einem Schiedsgremium etwas mehr als 590.000 ...
Despite being diagnosed with Amyotrophic Lateral Sclerosis, or ALS, a longtime coach at Northern Bedford County High School ...
A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and phosphorylated tau 181.
A charity hockey game is on the way to Western Michigan University's (WMU) Lawson Ice Arena this spring. Hosted by the Susan ...
Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback